Skip to main content

WPI 1118 (Mirtazapine 30 mg)

Pill with imprint WPI 1118 is Yellow, Elliptical/Oval and has been identified as Mirtazapine 30 mg. It is supplied by Watson Pharmaceuticals.

Mirtazapine is used in the treatment of depression; major depressive disorder and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 1118

Mirtazapine

Imprint
WPI 1118
Strength
30 mg
Color
Yellow
Size
13.00 mm
Shape
Elliptical/Oval
Availability
Prescription only
Drug Class
Tetracyclic antidepressants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
00591-1118 (Discontinued)
Inactive Ingredients
lactose anhydrous, silicon dioxide, magnesium stearate, microcrystalline cellulose, hypromellose 2910 (3 mPa.s), hypromellose 2910 (6 mPa.s), polyethylene glycol 400, polysorbate 80, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.